(Q42631161)

4 November 2017

title

Autoantibodies and SLE: the threshold for disease (English)

1 reference

4 November 2017

1 reference

Nancy J Olsen

1

1 reference

4 November 2017

David R Karp

series ordinal

2

1 reference

4 November 2017

language of work or name

English

0 references

publication date

3 December 2013

1 reference

Nature Reviews Rheumatology

4 November 2017

published in

1 reference

4 November 2017

volume

10

1 reference

4 November 2017

issue

3

1 reference

4 November 2017

page(s)

181-186

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2013.184

4 November 2017

exact match

0 references

cites work

Unmet medical needs in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

ANA screening: an old test with new recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Genetics, pathogenesis and clinical interventions in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Risk factors for ANA positivity in healthy persons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Prevalence of antinuclear autoantibodies in the serum of normal blood dornors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Range of antinuclear antibodies in "healthy" individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Incomplete lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Prevalence and sociodemographic correlates of antinuclear antibodies in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

The 1982 revised criteria for the classification of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Autoantibody profiling to follow evolution of lupus syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Estrogen directly activates AID transcription and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Expression of humoral autoimmunity is related to androgen receptor CAG repeat length in men with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Gonadal steroids and humoral immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Lots of autoantibodies equal lupus?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Environment and lupus-related diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Immunopathogenic mechanisms of systemic autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Reproductive and menopausal factors and risk of systemic lupus erythematosus in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Sun-induced life-threatening lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

The spectrum of ASIA: 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Autoantibodies in the diagnosis of systemicrheumatic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.184

Interaction of nuclei and globulin from lupus erythematosis serum demonstrated with fluorescent antibody

31 March 2020

1 reference

12 December 2020

Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.

1 reference

12 December 2020

The prevalence of antinuclear, anti-dsDNA, anti-Sm and anti-RNP antibodies in a group of healthy blood donors.

1 reference

12 December 2020

Epstein-Barr virus infection induces lupus autoimmunity.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2013.184

1 reference

Dimensions Publication ID

4 November 2017

1036976549

0 references

1 reference